Ensign Peak Advisors
TECH icon

Ensign Peak Advisors’s Bio-Techne TECH Stock Holding History

Ensign Peak Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Hold
9,627
– – ﹤0.01% 904
2026
Q1 		$503K Hold
9,627
– – ﹤0.01% 957
2025
Q4 		$566K Sell
9,627
-31,000
-76% -$1.88M ﹤0.01% 927
2025
Q3 		$2.26M Sell
40,627
-250
-0.6% -$13.4K ﹤0.01% 772
2025
Q2 		$2.1M Sell
40,877
-13,750
-25% -$691K ﹤0.01% 882
2025
Q1 		$3.2M Sell
54,627
-100
-0.2% -$6.78K 0.01% 753
2024
Q4 		$3.94M Hold
54,727
– – 0.01% 709
2024
Q3 		$4.37M Sell
54,727
-600
-1% -$45.1K 0.01% 669
2024
Q2 		$3.96M Sell
55,327
-4,000
-7% -$294K 0.01% 689
2024
Q1 		$4.18M Buy
59,327
+2,457
+4% +$176K 0.01% 677
2023
Q4 		$4.39M Buy
56,870
+11,000
+24% +$725K 0.01% 655
2023
Q3 		$3.12M Buy
45,870
+250
+0.5% +$19.7K 0.01% 699
2023
Q2 		$3.72M Hold
45,620
– – 0.01% 671
2023
Q1 		$3.38M Buy
45,620
+4,400
+11% +$339K 0.01% 670
2022
Q4 		$3.42M Sell
41,220
-3,900
-9% -$310K 0.01% 654
2022
Q3 		$3.2M Sell
45,120
-220
-0.5% -$19K 0.01% 640
2022
Q2 		$3.93M Buy
45,340
+620
+1% +$58.1K 0.01% 601
2022
Q1 		$4.84M Sell
44,720
-6,760
-13% -$697K 0.01% 606
2021
Q4 		$6.66M Buy
51,480
+44,164
+604% +$5.41M 0.01% 580
2021
Q3 		$887K Sell
7,316
-129,428
-95% -$15.8M ﹤0.01% 1474
2021
Q2 		$15.4M Hold
136,744
– – 0.03% 358
2021
Q1 		$13.1M Buy
136,744
+18,000
+15% +$1.64M 0.03% 371
2020
Q4 		$9.43M Hold
118,744
– – 0.02% 429
2020
Q3 		$7.35M Buy
118,744
+6,000
+5% +$390K 0.02% 517
2020
Q2 		$7.44M Buy
112,744
+800
+0.7% +$47.9K 0.02% 492
2020
Q1 		$5.31M Hold
111,944
– – 0.02% 493
2019
Q4 		$6.14M Buy
+111,944
New +$5.87M 0.02% 584

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ensign Peak Advisors's TECH Position: Q2 2026 in Review

Ensign Peak Advisors held its Bio-Techne (TECH) position steady in Q2 2026 at 9,627 shares worth $680K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

Ensign Peak Advisors first reported a position in TECH in Q4 2019 and has held it in 27 quarters since. The position peaked at $15.4M in Q2 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Ensign Peak Advisors held 9,627 shares of Bio-Techne worth $680K as of Q2 2026.
  • Ensign Peak Advisors left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #904 holding.
  • Ensign Peak Advisors first reported a position in Bio-Techne in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Bio-Techne position peaked at $15.4M in Q2 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.